Immuno supressants Flashcards
1
Q
Tacrolimus
A
Calcineurin inhibitor (maintenance phase)
- Inhibit transcription of IL-2, IF-g, and IL4 by preventing dephosphorylation of NFAT
- generally prevent activation or proliferation of T cells
- side effects: Renal toxicity, HTN, Neurotoxicity*
- Drug-interactions: CYP3A4 substrate
2
Q
Belatacept
A
- Monoclonal Ab
- Target CD80/86 (B7)
- prevents co-stim signal => apoptosis
- MUST be Epstein-Barr Virus positive (or => Post-Transplant lymphoproliferative disorder) (black box)
3
Q
Mycophenolate Mofetil
A
- Cell cycle disruptor (maintenance phase)
- Inhibit inosine monophosphate dehydrogenase (used for purine recycling => interrupt DNA synthesis => S phase arrest in T and B cells selectively)
- Side effects:
GI* tract problems, neutropenia*, infections and tumors
4
Q
Azathioprine
A
- Cell cycle disruptors (maintenance phase)
- Many products: Block co-stimulation by CD28=> apoptosis after IL2 stimulation, Fraudulent nucleotide* (S phase arrest)
- SE: Myelosuppressive, co-toxic w/ Allopurinol
5
Q
Muromonab
A
- Monoclonal Ab
- Target CD3; great for organ transplant
- prevents co-stim signal => apoptosis
- SE: murine protein sensitivity (Angioedema, hypovolemia, seizures)
6
Q
Thymoglobulin (Antithymocyte globulin)
A
- Polyclonal IgG against human T-lymphocytes
- Many targets; great for organ transplants
- Induction phase
7
Q
Sirolimus
A
mTOR inhibitor
=> G1 arrest (no cell cycling) prevent B-cell differentiation
- Drug-interactions: CYP3A4 substrate
- SE: Hyperlipidemia, Renal toxicity, Hepatotoxicity* (incl fatal necrosis)
8
Q
Cyclosporine
A
- Calcineurin inhibitor (maintenance phase)
- Inhibit transcription of IL2, IF-g, and IL4 by preventing dephospharylation of NFAT
- generally prevent activation or proliferation of T cells
- side effects: Hirsutism (hypertrichosis), Gingival Hyperplasia, Renal toxicity, HTN,
- Drug-interactions: CYP3A4 substrate
9
Q
Prednisone
A
- Nuclear transcription inhibitors: corticosteroids (anti-inflammatory)
- Inhibit histone acetyltransferase (also NFkB function)
- maintenance phase
- side effects: Protein metabolism dysfunction, infection susceptibility (esp TB), dyslipidemia* and assoc issues, neuropathy, impaired wound healing
10
Q
Basiliximab
A
- CD-25 antagonists (IL-2 receptor)
- inhibit activation by IL2
- Induction phase (NOT lymphocyte depleting)
- Side effects: Infection (including reactivating latent viruses), secondary malignancies
11
Q
Methotrexate
A
- Cell cycle disruptors (maintenance phase)
- inhibit de novo pyrimidine synthesis
- also ant-inflammatory (bind receptors on APCs)
- SE: GI, pulmonary fibrosis, neuro, hepatotoxicity